Publication date: Sep 22, 2023
The influence of the novel human coronavirus disease (COVID-19) pandemic on skin cancer characteristics in Latin America is still poorly elucidated. This was a cross-sectional study which included patients diagnosed with skin cancer (basal cell carcinoma [BCC], cutaneous squamous cell carcinoma [cSCC], and primary cutaneous melanoma [cMM]) during the first year of the COVID-19 pandemic (from March 1, 2020, to February 28, 2021) and the preceding year at our institution. The total number of skin cancer diagnoses and surgeries, as well as their topography, clinicopathological staging at diagnosis, and treatment delay were compared between the two periods. There was a 31. 8% reduction in skin cancer diagnoses during the first year of the COVID-19 pandemic at our institution. There was an increase in the proportion of low-risk cancers according to the NCCN guidelines for BCCs (40. 8-49%, P
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Skin cancer |
| disease | MESH | COVID-19 pandemic |
| pathway | KEGG | Coronavirus disease |
| disease | MESH | basal cell carcinoma |
| pathway | KEGG | Basal cell carcinoma |
| disease | MESH | squamous cell carcinoma |
| disease | MESH | melanoma |
| pathway | KEGG | Melanoma |
| disease | MESH | cancers |